← Leaderboards
Harry C. Dietz
Johns Hopkins University
$10,377,475
Attributed
$11,776,107
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$11,776,107 · 7
By mechanism
R01$7,112,335 · 3
P01$3,625,558 · 2
RC1$998,214 · 1
U13$40,000 · 1
Top collaborators
- Daniel S Warren5 shared
- Jennifer E Van Eyk2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Pere Puigserver$26,070,286
- Guang William Wong$7,353,539
- Timothy H. Moran$14,955,673
- Kerry J. Stewart$8,862,452
- Anastasia Kralli$8,302,946
Others in their field
Top investigators on “Marfan Syndrome”
- Francesco B Ramirez · Mount Sinai School Of Medicine Of Nyu$13,200,279
- Lynn A Sleeper · New England Research Institutes, Inc.$8,654,163
- Sharon L Tennstedt · New England Research Institutes, Inc.$8,654,163
- Dianna M Milewicz · University Of Texas Hlth Sci Ctr Houston$7,913,101
- Daniel B Rifkin · New York University School Of Medicine$7,205,651
- Lynn Y Sakai · Oregon Health And Science University$5,497,292
Research focus
Marfan SyndromeMouse ModelPhenotypeEventGeneticProteinsGenesSeveritiesSignal TransductionTissuesFbn1PerformanceMutationLosartanTransforming Growth Factor BetaBasePathway InteractionsAortaCellsAllelesNeutralizing AntibodyCessation Of LifeFamilyMolecular
Grant awards (37)
Mechanistic and Therapeutic Investigations of Scleroderma$360,250
R01 · FY2020 · AR · contact PI
Mechanistic and Therapeutic Investigations of Scleroderma$360,250
R01 · FY2019 · AR · contact PI
Mechanistic and Therapeutic Investigations of Scleroderma$360,250
R01 · FY2018 · AR · contact PI
Mechanistic and Therapeutic Investigations of Scleroderma$359,700
R01 · FY2017 · AR · contact PI
Molecular Biology of Marfan Syndrome$364,500
R01 · FY2016 · AR · contact PI
Mechanistic and Therapeutic Investigations of Scleroderma$358,600
R01 · FY2016 · AR · contact PI
Molecular Biology of Marfan Syndrome$364,500
R01 · FY2015 · AR · contact PI
Molecular Biology of Marfan Syndrome$357,210
R01 · FY2014 · AR · contact PI
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication$465,467
P01 · FY2013 · AR · contact PI
Molecular Biology of Marfan Syndrome$346,275
R01 · FY2013 · AR · contact PI
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication$483,128
P01 · FY2012 · AR · contact PI
Molecular Biology of Marfan Syndrome$364,500
R01 · FY2012 · AR · contact PI
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication$507,904
P01 · FY2011 · AR · contact PI
Novel Biomarkers in Aortic Aneurysms and Acute Aortic Dissection$498,214
RC1 · FY2010 · HL
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication$440,259
P01 · FY2010 · AR · contact PI
Molecular Biology of Marfan Syndrome$421,488
R01 · FY2010 · AR · contact PI
Systems Biology and Connective Tissue Disorders$40,000
U13 · FY2010 · AR · contact PI
Novel Biomarkers in Aortic Aneurysms and Acute Aortic Dissection$500,000
RC1 · FY2009 · HL
Developmental Basis of Aneurysm in Marfan Syndrome and Therapeutic Implication$449,200
P01 · FY2009 · AR · contact PI
Molecular Biology of Marfan Syndrome$343,331
R01 · FY2009 · AR · contact PI
Molecular Biology of Marfan Syndrome$283,133
R01 · FY2009 · AR · contact PI
Molecular Biology of Marfan Syndrome$41,000
R01 · FY2009 · AR · contact PI
Molecular Biology of Marfan Syndrome$343,331
R01 · FY2008 · AR · contact PI
Exploration of Therapeutic Strategies in Mar$281,316
P01 · FY2008 · AR · contact PI
Molecular Biology of Marfan Syndrome$123,000
R01 · FY2008 · AR · contact PI
Molecular Biology of Marfan Syndrome$349,892
R01 · FY2007 · AR · contact PI
Exploration of Therapeutic Strategies in Mar$242,201
P01 · FY2007 · AR · contact PI
Molecular Biology of Marfan Syndrome$359,425
R01 · FY2006 · AR · contact PI
PROJECT 4: Exploration of Therapeutic Strategies in Mar$259,514
P01 · FY2006 · AR · contact PI
PROJECT 4: Exploration of Therapeutic Strategies in Mar$251,955
P01 · FY2005 · AR
PROJECT 4: Exploration of Therapeutic Strategies in Mar$244,614
P01 · FY2004 · AR
MOLECULAR BIOLOGY OF THE MARFAN SYNDROME$226,959
R01 · FY2004 · AR
MOLECULAR BIOLOGY OF THE MARFAN SYNDROME$226,959
R01 · FY2003 · AR
MOLECULAR BIOLOGY OF THE MARFAN SYNDROME$226,959
R01 · FY2002 · AR
MOLECULAR BIOLOGY OF THE MARFAN SYNDROME$227,128
R01 · FY2001 · AR
MOLECULAR BIOLOGY OF THE MARFAN SYNDROME$227,636
R01 · FY2000 · AR
NONSENSE RNA SURVEILLANCE IN HEALTH AND DISEASE$116,059
R01 · FY2000 · GM